[Toxicity Management and Efficacy Evaluation of BCMA-CART in the Treatment of Relapsed and Refractory Multiple Myeloma].

Xiaoyuan Zhang(State Key Joint Laboratory of Environment Simulation and Pollution Control), Songfu Jiang(Wenzhou Medical University), Dongxu Gang(Wenzhou Medical University), Xiaoyu He(Wenzhou Medical University), Honglan Qian(Wenzhou Medical University), Hanyi Ding(Wenzhou Medical University), Yu Zhang(Nanfang Hospital), Chongyun Xing(Zhejiang Chinese Medical University), Yongyong Ma(Wenzhou Medical University), Xuanru Lin(Zhejiang University)
PubMed
April 1, 2022
10.19746/j.cnki.issn.1009-2137.2022.02.024
Cited by 1

Related Papers

Enhanced Anaerobic Wastewater Treatment by a Binary Electroactive Material: Pseudocapacitance/Conductance-Mediated Microbial Interspecies Electron Transfer
|Environmental Science & Technology|2023|149
Neglected role of iron redox cycle in direct interspecies electron transfer in anaerobic methanogenesis: Inspired from biogeochemical processes
|Water Research|2024|83
Prognostic Significance of Pretreatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients with Diffuse Large B-Cell Lymphoma
|BioMed Research International|2018|50
Control the greenhouse gas emission via mediating the dissimilatory iron reduction: Fulvic acid inhibit secondary mineralization of ferrihydrite
|Water Research|2022|42
Phase 1 Trial of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells in Relapsed/Refractory Multiple Myeloma
|Blood|2019|40